The payment code, effective Feb. 24, is for Evusheld. The FDA last month authorized a revised dose of the drug when it is used for prevention of COVID-19. The medication is for certain adults and pediatric patients who have compromised immune systems or who are unable to get the COVID-19 vaccine due to a history of severe adverse reaction.
The new code is Q0221.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
